Dermatologic Disease
25
6
7
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 25 trials
100.0%
+13.5% vs benchmark
4%
1 trials in Phase 3/4
8%
1 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (25)
Vitiligo Registry for Adults and Children in the UK
Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus
A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis
A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
Psorcast Mobile Study
A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone
Effect of Vitamin D Injection on Hypertrophic Scars and Keloids
The Impact of Chronic Adolescent Skin Conditions on Sexual Health
Photodynamic Therapy and Topical Antifungal for Onychomycosis in Patients With Diabetes.
Cross-condition Validation of the Steroid PRO
Impact of Spa Treatments on the Consumption of Care in Children
Addressing Inequity in Dermatology
Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children
Collection and Distribution of Biospecimens for Novel Research
Collection and Distribution of Biospecimens for Novel Research Uses
Investigating Compassion-Based Guided Self-Help for Depression in People With Skin Conditions
The State of Sexual Development in Children With Inherited Epidermolysis Bullosa
Testing a Body-functionality Intervention for Body Image in Individuals With Skin Conditions
Personal Precise Treatment on Psoriasis and Psoriatic Arthritis
Acceptance of Telemedicine in Dermatology Patients, Physicians and Medical Staff